Estimating meaningful change for The Impact of Weight on Self-Perception (IW-SP) questionnaire among people with type 2 diabetes.

"Declarations Conflict of interestHelene Sapin, Jiat Ling Poon, and Kristina Boye are employed by- and shareholders of- Eli Lilly and Company, Indianapolis, IN, USA; Heather L. Gelhorn and Stephen Maher are employed by Evidera, Bethesda, MD, USA. Consent to participateAll the patients provided written informed consent—see approved protocol: https://www.nejm.org/doi/suppl/10.1056/NEJMoa2107519/suppl_file/nejmoa2107519_protocol.pdf. Ethical approvalThis was a reanalysis of clinical trial data from the SURPASS-2 trial (cited above), which was approved by local institutional review boards and was conducted in accordance with the principles of the Declaration of Helsinki and in accordance with the Good Clinical Practice guidelines of the International Council for Harmonisation. All the patients provided written informed consent. Approved protocol: https://www.nejm.org/doi/suppl/10.1056/NEJMoa2107519/suppl_file/nejmoa2107519_protocol.pdf. Conflict of interest Helene Sapin, Jiat Ling Poon, and Kristina Boye are employed by- and shareholders of- Eli Lilly and Company, Indianapolis, IN, USA; Heather L. Gelhorn and Stephen Maher are employed by Evidera, Bethesda, MD, USA."

"Funding Funding was provided by Eli Lilly and Company."